Scancell Holdings (GB:SCLP) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Scancell Holdings plc, a developer of cancer immunotherapies, has appointed Dr. Florian Reinaud as a Non-Executive Director to its Board. With over two decades of experience in the healthcare sector, Reinaud’s extensive background spans executive roles, investment expertise, and a medical career, including his current position at Redmile Group, an investment firm focused on healthcare. His appointment is expected to bring considerable value to Scancell as it progresses its lead assets through advanced clinical trials.
For further insights into GB:SCLP stock, check out TipRanks’ Stock Analysis page.
